Member Info for Vascular

"Dividend Growth Stocks to buy for 2018 Kromek Group � �25.45 (Down 0.20%) Market Capitalisation � �66.4 Billion The Motley Fool identifies Kromek as a must buy growth stock for 2018 dividend yields and more. A producer of X-ray, Gamma Ray imaging and radiation detection products, it carries a robust reputation. Across the year, Kromek is expecting a revenue of �12.5 million across the year and holds a 5-year contract on its technology.

called "Countering Weapons of Mass Destruction Office" set up December 2017 https://www.dhs.gov/countering-weapons-mass-destruction-office Strategic Goals �Champion and lead the development of a unified United States Government strategy for a robust Global Nuclear Detection Architecture (GNDA) and effective National Technical Nuclear Forensics (NTNF) capabilities �Invest in and develop innovative technologies to meet partner requirements and make operations better �Strengthen GNDA and NTNF operations, ensuring readiness �DNDO will be an organization that others use as a benchmark, in terms of staff expertise, opportunities, and morale

I have lost the link to the Sigma rollout / positive news I referred to in my last post as I was on my mobile at the time....but I did stumble across this dated 8th Jan 18 which also looks very positive and may have some bearing on the recent blue days this past week. "The Department of Homeland Security (DHS), for one, is setting up a new office�Countering Weapons of Mass Destruction�that will concentrate its efforts to combat what DHS officials say is a real threat." "We have credible evidence of an increase in terrorists wanting to use chemical, biological, radiological, and nuclear weapons against us,� James McDonnell, DHS assistant secretary for countering weapons of mass destruction (WMD) and director of the department�s Domestic Nuclear Detection Office, told a congressional hearing last month. �Certain WMDs, once thought impossible for non-state actors to acquire, are now getting into the hands of those who would seek to use them against us.� "Mobile, low-cost radiation detectors could help in the response, which is the goal of the defence Advanced Research Projects Agency�s (DARPA) SIGMA program, which has tested a radiation-monitoring network that can operate continuously in a large city or region. DARPA said the low-cost detectors�developed since 2014 in a collaboration of industry, national laboratories, and academic institutions�could be available to local, state, and Federal agencies this year." https://www.meritalk.com/articles/program-goes-mobile-to-detect-dirty-bomb-fallout/

I think there's been some posative noises from Sigma / Darpa regarding increasing threats identified in US along with a mention of handheld and static rollout likely in 2018....looks v. Posative for this year....

I agree about IC. I don't follow it but wondered why the steady buying and the occasional larger sells... . Maybe they have KMK in weekly magazine ...or another posative tip somewhere else...someone's taking the opportunity of selling though...we are due further news soon surely!

Anyone any idea why all the buys...it's Been five days since IC tip?

Thanks Swiss . I was wondering why the blue.

Just a matter of waiting for the big orders....imo. Kmk have three months to announce a few smaller orders to hit forecasts ...which in itself will please the market, could easily surpass expectations....it's all down to time. Can't see any negatives either...other than boredom.I thought it was an excellent review of kmk potential. Don't care who wrote it really.

Thanks Orangetree for your assessment of KMK. I notice you provide a share tip / review service. I take on board your assessment of KMK and agree with you in general about the day to day contracts that have so far been won by Kromek. If things continue as in past it will be a wait until profit...but as you are aware many are invested here because of the technology ( which is cutting edge, so I believe...and we are told by The BODs ).....I personally think a breakthrough ( large contracts unlike ones seen so far) in one or more of KMKs three divisions could transform your calculations over night....from what I have read their technology does seem quite disruptive / or a must have in the security and medical markets...you do not seem to have taken any of these future possibility into account.....which is the main attraction of investing in KMK In the first place. All the best Vas.

Following recent interims. http://www.thenorthernecho.co.uk/business/15780969.Kromek_hails__turning_point_year__as___1_1m_healthcare_deal_adds_momentum_to_order_book/

Have given some good coverage, even though nothing new. http://www.tech-capital.com/companies/news/188990/kromek-on-course-for-ebitda-break-even-this-financial-year-188990.html

Again this sentence from rns "D3S sensors continued to be field-tested in major areas of strategic importance to the US by DARPA, and by other public administrations across the globe". Note the line... "Other areas of strategic importance"...not necessarely just inside US but maybe middle East. ...defenitely imo the European Uniion. If you search other country's the likes of many come up as suitably concerned and are seemingly doing what US are doing...Inda, Canada, china even Argentina. Just to name a few ..not saying they are same stage or we are involved but are looking for solutions....

RNS. i found this paragraph very interesting as it implies that the USA ( as we know a massive market in itself) are not alone in wanting a defence against rogue dirty bomb attacks etc....and I would love to know which other countrys across the globe are also field testing this system using KMKs D3S detectors. DARPA may use their extensive research into country wide radiation technology in US to up sell the product abroad maybe,,,to recoup some of the money spent researching it ....I don’t know....anyone got anything in which other country’s are field testing...? From RNS... “D3S sensors continued to be field-tested in major areas of strategic importance to the US by DARPA, and by other public administrations across the globe”

Well all I know is that the present day market cap only reflects todays day to day business that is RNS,. When one or both of KMKs strategic 2 billion makets come into play. As promised.....this will be multiples of today's price...company doing OK. ..winning orders just need a couple of humongous ones to show what the company is capable of....that's what I am hanging around for...not the day to day stuff...which should break even at some stage.

To be fair and playing devils advocate....it's is still only 2017. Imo its significant that they have drawn our attention in the interims to the recent $8.2 Billion funding for Home a Defence contracts.....Might be a clue...

"UPDATE: On November 1, 2017 Army Contracting Command-Natick, Massachusetts announced the award of JE-RDAP to 170 awardees, out of 178 bids received. The awardees will share the $8,276,161,000 award with a completion date in 2027. The US Military is fielding two major contracts, worth $8.27 billion and $980 million, through the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) and the Defense Threat Reduction Agency. With both contracts centered, in part, on Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) intervention and response, these will present important federal procurement opportunities for specialized service providers. Building off our prior analysis of the $980 million DTRA contract, EZGovOpps is now bringing you an exclusive look at the massive $8.27 billion contract which is still accepting proposals." KMK already Involved and contracted ....so should be good. https://ezgovopps.com/home/research/je-rdap-military-chem-bio-programs/

"Named as a qualified contractor under the recently-announced $8.2bn U.S. Department of Defense IDIQ for the Joint Enterprise - Research, Development, Acquisition, and Production/Procurement contract award vehicle fo....."

Evening Fuk79, I agree about the pace but on balance I prefer a share that's pretty stable...if at times a bit boring..I'm really pleased that the China " long term" contract is still in play....as it's just another possibility along with so many others...one of these big orders must fall sometime....so I'm buying and holding as well...if the interims are good...should lead to some more coverage....

This from KMK in March 2017 "Although the last two contract wins were both from US-based customers, Dr Basu is excited about the growth opportunities available in Asia, and in particular China, on the medical imaging side of the business. "Technology is being embraced and developed in China at a rapid rate," he said in response to a question about whether he had misgivings about dealing with China, given its reputation for being on the free and easy side in terms of respecting patents and intellectual property. "You can either ignore China or you can embrace it. The key is finding the right partner," he said." http://www.proactiveinvestors.co.uk/companies/news/174360/kromek-surges-as-it-bags-us990k-us-contract-174360.html If this one comes good we will surely be multiples of today's price....let alone all the other possibilities....

Here's my e mail sent last night. "Sent: 13 December 2017 22:20 To: Sales <sales@kromek.com> Subject: Question Dear Sir or Madam, I am a private investor and would like to clarify something. Regarding the large Medical Imaging contract in China in April 2014 , which was a seven year length. Can you confirm that this is the same Chinese company that you referred to recently in the final results rns in June 2017. Is the original $159 million contract still in progress. Thanks in advance Best Regards," The reply received was basically " yes, I can confirm you are correct"